Migraine and risk of cardiovascular disease in women: Prospective cohort study

BMJ (Online)

Volumn 353, Issue , 2016, Pages

  Kurth, Tobias ^a,b,c   Winter, Anke C ^d   Eliassen, A Heather ^c,e   Dushkes, Rimma ^a   Mukamal, Kenneth J ^c   Rimm, Eric B ^c,e   Willett, Walter C ^c   Manson, Joann E ^a,c,e   Rexrode, Kathryn M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE MARKER; FATALITY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HORMONAL THERAPY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MIGRAINE; ORAL CONTRACEPTIVE USE; OUTCOMES RESEARCH; POSTMENOPAUSAL HORMONE THERAPY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; CARDIOVASCULAR DISEASES; CAUSALITY; MIDDLE AGED; MIGRAINE DISORDERS; MORTALITY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; CARDIOVASCULAR DISEASES; CAUSALITY; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; MYOCARDIAL REVASCULARIZATION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC; UNITED STATES;

EID: 84974782506     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i2610     Document Type: Article

References (43)

1. Stovner Lj, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210. doi:10.1111/j.1468-2982.2007.01288.x.
2. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808. doi:10.1177/0333102413485658.
3. Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 2015;55:21-34. doi:10.1111/head.12482.
4. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated metaanalysis. Am J Med 2010;123:612-24. doi:10.1016/j. amjmed.2009.12.021.
5. Sacco S, Ornello R, Ripa P, Pistoia F, Carolei A. Migraine and hemorrhagic stroke: a meta-analysis. Stroke 2013;44:3032-8. doi:10.1161/STROKEAHA.113.002465.
6. Kurth T, Chabriat H, Bousser M-G. Migraine and stroke: a complex association with clinical implications. Lancet Neurol 2012;11:92-100. doi:10.1016/S1474-4422(11)70266-6.
7. Mawet J, Kurth T, Ayata C. Migraine and stroke: in search of shared mechanisms. Cephalalgia 2015;35:165-81. doi:10.1177/0333102414550106.
8. Napoli R, Guardasole V, Zarra E, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology 2009;72:2111-4. doi:10.1212/WNL.0b013e3181aa53ce.
9. Liman TG, Bachelier-Walenta K, Neeb L, et al. Circulating endothelial microparticles in female migraineurs with aura. Cephalalgia 2015;35:88-94. doi:10.1177/0333102414529671.
10. Tietjen GE, Al-Qasmi MM, Athanas K, Utley C, Herial NA. Altered hemostasis in migraineurs studied with a dynamic flow system. Thromb Res 2007;119:217-22. doi:10.1016/j.thromres.2005.12.020.
11. Scher AI, Terwindt GM, Picavet HSJ, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-20. doi:10.1212/01. WNL.0000151857.43225.49.
12. Malik R, Freilinger T, Winsvold BS, et al. International Headache Genetics Consortium METASTROKE Collaboration of the International Stroke Genetics Consortium. Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. Neurology 2015;84:2132-45. doi:10.1212/WNL.0000000000001606.
13. Schürks M, Buring JE, Ridker PM, Chasman DI, Kurth T. Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS One 2011;6:e22106. doi:10.1371/journal.pone.0022106.
14. Eikermann-Haerter K. Spreading depolarization may link migraine and stroke. Headache 2014;54:1146-57. doi:10.1111/head.12386.
15. Dreier JP, Reiffurth C. The stroke-migraine depolarization continuum. Neuron 2015;86:902-22. doi:10.1016/j.neuron.2015.04.004.
16. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology 2005;64(Suppl 2):S9-15. doi:10.1212/WNL.64.10-suppl-2.S9.
17. Longoni M, Ferrarese C. Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 2006;27(Suppl 2):S107-10. doi:10.1007/s10072-006-0582-2.
18. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-91. doi:10.1001/jama.296.3.283.
19. Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: a population-based study. Neurology 2010;74:628-35. doi:10.1212/WNL.0b013e3181d0cc8b.
20. Wang Y-C, Lin C-W, Ho Y-T, Huang YP, Pan SL. Increased risk of ischemic heart disease in young patients with migraine: a population-based, propensity score-matched, longitudinal follow-up study. Int J Cardiol 2014;172:213-6. doi:10.1016/j.ijcard.2014.01.005.
21. Gudmundsson LS, Scher AI, Aspelund T, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ 2010;341:c3966. doi:10.1136/bmj. c3966.
22. Schürks M, Buring JE, Kurth T. Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia 2009;29:1086-90. doi:10.1111/j.1468-2982.2008.01835.x.
23. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol 1984;119:837-9.
24. Rose GA, Blackburn H, Gillum RF, et al. Cardiovascular survey methods.World Health Organization, 1982.
25. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke. Clinical findings. Stroke 1981;12(Suppl 1):I13-44.
26. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007;167:795-801. doi:10.1001/archinte.167.8.795.
27. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation 2011;123:1243-62. doi:10.1161/CIR.0b013e31820faaf8.
28. Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914. doi:10.1136/bmj.b3914.
29. Sternfeld B, Stang P, Sidney S. Relationship of migraine headaches to experience of chest pain and subsequent risk for myocardial infarction. Neurology 1995;45:2135-42. doi:10.1212/WNL.45.12.2135.
30. Rose KM, Carson AP, Sanford CP, et al. Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology 2004;63:2233-9. doi:10.1212/01.WNL.0000147289.50605.DC.
31. Oral contraceptives and stroke in young women. Associated risk factors. JAMA 1975;231:718-22. doi:10.1001/jama.1975.03240190022010.
32. Tzourio C, Tehindrazanarivelo A, Iglésias S, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995;310:830-3. doi:10.1136/bmj.310.6983.830.
33. MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007;38:2438-45. doi:10.1161/STROKEAHA.107.488395.
34. Kurth T, Schürks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, cardiovascular events in women: prospective cohort study. BMJ 2008;337:a636. doi:10.1136/bmj.a636.
35. Liman TG, Neeb L, Rosinski J, et al. Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study. Cephalalgia 2012;32:459-66. doi:10.1177/0333102412444014.
36. González-Quintanilla V, Toriello M, Palacio E, et al. Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator. Cephalalgia 2016;36:552-60. doi:10.1177/0333102415607857.
37. Totaro R, Marini C, De Matteis G, Di Napoli M, Carolei A. Cerebrovascular reactivity in migraine during headache-free intervals. Cephalalgia 1997;17:191-4. doi:10.1046/j.1468-2982.1997.1703191.x.
38. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007;68:1563-70. doi:10.1212/01.wnl.0000260964.28393.ed.
39. Rose KM, Wong TY, Carson AP, Couper DJ, Klein R, Sharrett AR. Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology 2007;68:1694-700. doi:10.1212/01.wnl.0000261916.42871.05.
40. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999;53:537-42. doi:10.1212/WNL.53.3.537.
41. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-57. doi:10.1046/j.1526-4610.2001.041007646.x.
42. Buettner C, Burstein R. Association of statin use and risk for severe headache or migraine by serum vitamin D status: a cross-sectional population-based study. Cephalalgia 2015;35:757-66. doi:10.1177/0333102414559733.
43. Buettner C, Nir R-R, Bertisch SM, et al. Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial. Ann Neurol 2015;78:970-81. doi:10.1002/ana.24534.